儿童血性腹泻与产志贺毒素大肠埃希菌溶血性尿毒综合征:ItalKid-HUS网络数据
共筛查4767名儿童,214名(4.5%)阳性,34名(15.9%)发展为STEC-HUS(占血性腹泻的0.71%);所有HUS患者均有血红蛋白尿,仅Stx2阳性者HUS风险更高(23.7% vs 12.7%),仅Stx1阳性者无HUS发生。筛查发现的HUS患者就诊时血肌酐显著低于其他患者(中位数0.9 vs 1.51 mg/dL)。
要点
- 血性腹泻患儿中近1%发展为STEC-HUS,筛查Stx可提前诊断。
- 仅Stx2阳性者HUS风险高于Stx1+2或Stx1阳性者,仅Stx1阳性者无HUS。
- 建议对血性腹泻筛查Stx,对Stx2携带者监测尿血红蛋白尿以早期发现肾并发症。
核心结论
- 血性腹泻儿童中近1%发生STEC-HUS,筛查Stx可提前诊断HUS。
- 建议对血性腹泻筛查Stx,并建议对Stx2携带者监测尿血红蛋白尿以尽早识别肾脏并发症。
研究设计与样本
- 对血性腹泻患者粪便筛查志贺毒素基因,阳性者补液并监测血红蛋白尿直至腹泻缓解或诊断STEC-HUS。
主要发现
- 共筛查4767名儿童,214名(4.5%)阳性;Stx1阳性29.0%,Stx2阳性45.3%,Stx1+2阳性25.7%。
- 34名(15.9%)阳性患者发展为STEC-HUS,占血性腹泻的0.71%。
- 所有HUS患者均有血红蛋白尿;仅Stx2阳性者HUS风险更高(23.7% vs 12.7%),仅Stx1阳性者无HUS发生。
- 同期另有95名STEC-HUS患者未被筛查方案捕获(26例无血性腹泻,11例来自未覆盖地区,58例未转诊至筛查方案但符合纳入标准)。
- 筛查发现的HUS患者就诊时血肌酐显著低于其他患者(中位数0.9 vs 1.51 mg/dL)。
关键数值与推荐
- 血性腹泻患儿中STEC-HUS发生率为0.71%。
- 筛查阳性患者中STEC-HUS发生率为15.9%。
- 仅Stx2阳性者HUS风险为23.7%,Stx1+2阳性者为12.7%。
- 筛查发现HUS患者血肌酐中位数0.9 mg/dL,其他患者为1.51 mg/dL。
临床怎么用
- 对血性腹泻患儿应筛查志贺毒素基因以早期识别STEC感染。
- 对Stx2携带者建议监测尿血红蛋白尿以及早发现HUS肾并发症。
局限性
- 同期有95名STEC-HUS患者未被筛查方案捕获,包括无血性腹泻、地区未覆盖及未转诊者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To analyze the results of an enhanced laboratory-surveillance protocol for bloody diarrhea aimed at identifying children with Shiga toxin-producing Escherichia coli (STEC) infection early in the course of the disease toward the early identification and management of patients with hemolytic uremic syndrome (HUS). STUDY DESIGN: The study (2010-2019) involved a referral population of 2.3 million children. Stool samples of patients with bloody diarrhea were screened for Shiga toxin (Stx) genes. Positive patients were rehydrated and monitored for hemoglobinuria until diarrhea resolved or STEC-HUS was diagnosed. RESULTS: A total of 4767 children were screened; 214 (4.5%) were positive for either Stx1 (29.0%) or Stx2 (45.3%) or both Stx1+2 (25.7%); 34 patients (15.9%) developed STEC-HUS (0.71% of bloody diarrheas). Hemoglobinuria was present in all patients with HUS. Patients with Stx2 alone showed a greater risk of STEC-HUS (23.7% vs 12.7%) and none of the patients with Stx1 alone developed HUS. During the same period of time, 95 other patients were diagnosed STEC-HUS but were not captured by the screening program (26 had nonbloody diarrhea, 11 came from areas not covered by the screening program, and 58 had not been referred to the screening program, although they did meet the inclusion criteria). At HUS presentation, serum creatinine of patients identified by screening was significantly lower compared with that of the remaining patients (median 0.9 vs 1.51 mg/dL). CONCLUSIONS: Nearly 1% of children with bloody diarrhea developed STEC-HUS, and its diagnosis was anticipated by the screening program for Stx. The screening of bloody diarrhea for Stx is recommended, and monitoring patients carrying Stx2 with urine dipstick for hemoglobinuria is suggested to identify the renal complication as early as possible.
引用
- Ardissino G, Vignati C, Masia C, et al. Bloody Diarrhea and Shiga Toxin-Producing Escherichia coli Hemolytic Uremic Syndrome in Children: Data from the ItalKid-HUS Network. J Pediatr. 2021. PMID: 34197890. doi:10.1016/j.jpeds.2021.06.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。